Wealth Growth Daily

Top News

Samsung In Talks With OpenAI And Perplexity AI For Galaxy S26

BY Anusuya Lahiri  • July 25, 2025July 25, 2025
Samsung Electronics (OTC:SSNLF) is actively negotiating with OpenAI and Perplexity AI to bring a broader range of AI services to its next-generation Galaxy devices. The company aims to move beyond exc[...]
Read more
Top News

Fastenal, Rocket Companies, Toll Brothers And More On CNBC’s ‘Final Trades’

BY Avi Kapoor  • July 23, 2025July 23, 2025
Can a strategic stake increase in Rocket Companies, Inc. (NYSE:RKT) signal a seismic shift in investor sentiment, or is it merely a blip on the financial radar? As industry heavyweights weigh in with[...]
Read more
Top News

Ethereum Roars To $3,800: What’s Driving The Surge?

BY Murtuza J Merchant  • July 21, 2025July 21, 2025
Ethereum‘s (CRYPTO: ETH) most recent breakout isn’t just a product of ETF hype, it’s backed by a surge in DeFi activity and a rising structural shift, according to a 10x Research rep[...]
Read more
Top News

Marvell Reshuffles Leadership As It Looks To Reignite Momentum, Rebuild Investor Confidence

BY Anusuya Lahiri  • July 18, 2025July 18, 2025
Fabless semiconductor company Marvell Technology (NASDAQ:MRVL) announced two key leadership promotions effective July 15, 2025. Chris Koopmans has been elevated to president and CEO, while Sandeep Bha[...]
Read more
Top News

What’s Going On With Rigetti Computing Stock Today?

BY Nabaparna Bhattacharya  • July 16, 2025July 16, 2025
Rigetti Computing, Inc. (NASDAQ:RGTI) shares edged slightly lower during Wednesday’s premarket trading session, even as the quantum computing firm reported a notable performance breakthrough on[...]
Read more
Top News

AstraZeneca’s Drug Shows Promise For Resistant Hypertension In Phase 3 Trial

BY Vandana Singh  • July 14, 2025July 14, 2025
AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the BaxHTN Phase 3 trial of baxdrostat in patients with uncontrolled or treatment-resistant hypertension. The trial included patients[...]
Read more
Top News

Jamie Dimon Warns Market May Be Underestimating Rate Hike Risks

BY Namrata Sen  • July 11, 2025July 11, 2025
JP Morgan (NYSE:JPM) CEO Jamie Dimon has raised a red flag about the potential underestimation of the risk of higher U.S. interest rates by the financial markets. What Happened: Dimon expressed his co[...]
Read more
Top News

Top 2 Tech Stocks That May Plunge This Month

BY Avi Kapoor  • July 9, 2025July 9, 2025
As of July 9, 2025, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum[...]
Read more
Top News

Tesla, Array Technologies and Other Big Stocks Moving Lower

BY Avi Kapoor  • June 30, 2025June 30, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell in pre-market trading. Tesla researcher Troy Teslike has h[...]
Read more
Top News
« Previous 1 … 13 14 15 16 17 … 300 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551